NEWPORT BEACH--- Over 30 Early-Stage Medical Technology Start-Ups from Around the World Are Confirmed to Present at Medtech Insi
Medtech Insight, a division of Windhover Information, has announced that over 30 early-stage medical technology companies from a variety of countries including Switzerland, Germany, the U.K., Finland, Sweden, Belgium, France, the U.S. and Israel are confirmed to present thus far at its premier "Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies" conference in Brussels, Belgium, Sept. 20-21. In total, 50 emerging companies are expected to present at this conference.
In3 EUROPE, Medtech Insight's first "Investment In Innovation" medical technology strategic partnering and investment event outside of the U.S., will be held at The Crowne Plaza Brussels City Centre Hotel. The conference is designed to bring together emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership with major medical technology and investment dealmakers.
Presenting companies confirmed thus far with new technologies that address a variety of high-growth clinical areas include: ABMI, Aeres Medical, AI Semi, Ars Arthro, Biomarker Technologies, Biomedix, Biophan-Europe, Bioretec, Cardio3, CeMines, Clearant, CoolTouch, Emcision, eRAD-Image Medical, Hemoteq, HIRUDICA, Innovate, Innovent Medical Solutions, LiverCyte, Medical Tactile, MILLiMED, MINVASYS, NanoCyte, Novovascular, NuAce Technologies, Oxford Biosensors, PlaCor, Power Paper, QuiCare, Scientific Intake, Spinelix, Suriasis, Vascular Reconditioning, and ViOPtix (50 presenters at time of event). Regularly updated event details are posted on the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html.
The In3 EUROPE program will also feature presentations by Olav Bergheim, formerly a general partner at Domain Associates who has recently launched a new healthcare investment firm called Fjord Ventures where he is the founder and managing director, and Stefan Widensohler, president and CEO of KRAUTH Medical. Event co-sponsors include Battelle, Business Wire, Factory, Ronald Trahan Associates, and TforG.
An informative and interactive industry panel discussion titled "Venture Investing from a European Perspective" will take place, and will feature such distinguished panelists as Antoine Papiernik, managing partner at Sofinnova Partners; Berthold Hackl, managing partner at Heidelberg Innovation; and Daniel Gottlieb, group manager, business development, international at Guidant Compass. The session moderator will be David Cassak, managing partner at Windhover Information.
The In3 EUROPE audience will represent most of the major investment firms and medical technology companies worldwide. Among the companies confirmed to attend are: 3i Group, Abbott Laboratories, Arrow International, Atlas Venture, Bayer Innovation, BD, Bionest, Boston Scientific, Bourget International, Capman, CH-Werfen, C.R. Bard, Datascope, DePuy, DSM Venturing And Business Development, Earlybird Ventures, Eastman Chemical Company, Edwards Lifesciences, Ethicon Endo-Surgery, Guidant, Johnson & Johnson, Kimberly-Clark, Krauth Medical, Landesbank Baden-Wuerttemberg, LSP Services Deutschland, Medicor Medical Supplies, Medtronic, Misgav Technology Center, Morgan Stanley, NDI Europe, Nippon Sigmax Company, Rothschild Gestion-Paris, Seleon, Smiths Medical, Spacelabs Medical, SPEF Venture, Stryker, Teijin Pharma, Tyco Healthcare, and Vitatron, among many others.
The company's past U.S. "Investment In Innovation" conferences have hosted over 560 early-stage presenting medical companies and more than 4,800 attendees, making it one of the most successful networking and partnering events in the medical device industry. For more information or to register to attend the In3 EUROPE event, contact Kristy Grimes of Medtech Insight at 480-985-9512, e-mail kristy@medtechinsight.com, or visit the Medtech Insight Web site at http://www.medtechinsight.com/in3-europe-01.html. Through July 29, attendees registering for the conference can save $300 off the $1,495 registration fee.
A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.